S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
MarketBeat Week in Review – 4/15 - 4/19
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
MarketBeat Week in Review – 4/15 - 4/19
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
MarketBeat Week in Review – 4/15 - 4/19
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
MarketBeat Week in Review – 4/15 - 4/19
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion

CNS Pharmaceuticals (CNSP) Institutional Ownership

$0.20
0.00 (0.00%)
(As of 04/19/2024 ET)

Institutional Ownership Changes (13F Filings) for CNS Pharmaceuticals (NASDAQ:CNSP)

Current
Institutional Ownership
Percentage
14.02%
Number of
Institutional Buyers
(last 12 months)
8
Total
Institutional Inflows
(last 12 months)
$461.62K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$9.23K
Get CNSP Insider Trade Alerts

Want to know when executives and insiders are buying or selling CNS Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

CNSP Institutional Buying and Selling by Quarter

CNS Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/11/2024Vanguard Group Inc.58,369$74K0.0%+145.6%0.940%
2/13/2024Armistice Capital LLC122,000$155K0.0%N/A1.965%
1/17/2024Smith Anglin Financial LLC50,000$64K0.0%N/A0.952%
8/14/2023State Street Corp22,556$50K0.0%N/A1.011%
8/11/2023Geode Capital Management LLC16,142$36K0.0%N/A0.724%
8/7/2023Acadian Asset Management LLC22,292$49K0.0%N/A1.000%
7/12/2023FSM Wealth Advisors LLC16,334$38K0.0%N/A0.732%
5/16/2023Armistice Capital LLC124,000$124K0.0%-6.9%5.571%
5/12/2023Renaissance Technologies LLC26,800$27K0.0%N/A1.204%
2/15/2023Armistice Capital LLC133,229$320K0.0%N/A0.999%
8/13/2022Virtu Financial LLC178,184$50K0.0%+59.5%0.445%
5/17/2022Virtu Financial LLC111,749$38K0.0%N/A0.279%
5/13/2022Renaissance Technologies LLC506,532$173K0.0%+242.9%1.265%
5/13/2022Vanguard Group Inc.427,703$146K0.0%-29.8%1.068%
5/11/2022Bank of New York Mellon Corp234,892$80K0.0%+689.3%0.587%
9/17/2021Virtu Financial LLC20,745$41K0.0%-49.8%0.076%
8/13/2021Renaissance Technologies LLC432,109$847K0.0%-40.2%1.704%
8/13/2021Geode Capital Management LLC100,196$196K0.0%+64.8%0.395%
8/13/2021Vanguard Group Inc.599,309$1.18M0.0%+326.6%2.363%
8/11/2021Commonwealth Equity Services LLC20,000$39K0.0%N/A0.079%
5/19/2021Virtu Financial LLC41,310$99K0.0%N/A0.163%
5/18/2021Citadel Advisors LLC92,404$221K0.0%N/A0.364%
5/18/2021Jane Street Group LLC13,747$33K0.0%N/A0.054%
5/17/2021Goldman Sachs Group Inc.11,566$28K0.0%N/A0.046%
5/13/2021Renaissance Technologies LLC722,760$1.73M0.0%N/A2.850%
5/13/2021Bank of New York Mellon Corp43,659$104K0.0%N/A0.172%
5/12/2021Northern Trust Corp32,094$77K0.0%N/A0.127%
5/12/2021Geode Capital Management LLC60,784$145K0.0%N/A0.240%
2/16/2021Warberg Asset Management LLC14,000$25K0.0%N/A0.059%
11/12/2020Essex Investment Management Co. LLC61,563$108K0.0%-13.5%0.370%
5/4/2020Essex Investment Management Co. LLC71,494$150K0.0%-7.7%0.435%
(Data available from 1/1/2016 forward)

CNSP Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CNSP shares?

During the previous two years, 10 institutional investors and hedge funds held shares of CNS Pharmaceuticals. The most heavily invested institutionals were Armistice Capital LLC ($155K), Bank of New York Mellon Corp ($80K), Vanguard Group Inc. ($74K), Smith Anglin Financial LLC ($64K), State Street Corp ($50K), Virtu Financial LLC ($50K), and Acadian Asset Management LLC ($49K).Learn more on CNSP's institutional investors.

What percentage of CNS Pharmaceuticals stock is owned by institutional investors?

14.02% of CNS Pharmaceuticals stock is owned by institutional investors. Learn more on CNSP's institutional investor holdings.

Which institutional investors have been buying CNS Pharmaceuticals stock?

Of the 10 institutional investors that purchased CNS Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Renaissance Technologies LLC ($385.63K), Armistice Capital LLC ($255.23K), Bank of New York Mellon Corp ($205.13K), Virtu Financial LLC ($178.18K), Smith Anglin Financial LLC ($50K), Vanguard Group Inc. ($34.60K), and State Street Corp ($22.56K).

How much institutional buying is happening at CNS Pharmaceuticals?

Institutional investors have bought a total of 1,186,107 shares in the last 24 months. This purchase volume represents approximately $8.25M in transactions.

Which CNS Pharmaceuticals major shareholders have been selling company stock?

The following institutional investors have sold CNS Pharmaceuticals stock in the last 24 months: Vanguard Group Inc. ($181.71K), and Armistice Capital LLC ($9.23K).

How much institutional selling is happening at CNS Pharmaceuticals?

Institutional investors have sold a total of 190,935 shares in the last 24 months. This volume of shares sold represents approximately $1.87M in transactions.


This page (NASDAQ:CNSP) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners